High Ki67 proliferation index but not cell-of-origin subtypes is associated with shorter overall survival in diffuse large B-cell lymphoma

High Ki67 proliferation index but not cell-of-origin subtypes is associated with shorter overall survival in diffuse large B-cell lymphoma

Background: CD10, BCL6, and MUM1 are commonly used immunohistochemical stains for classifying diffuse large B-cell lymphoma (DLBCL), which is useful in predicting outcome. Conflicting reports of the prognostic value of other markers such as BCL2, CD23, and Ki67 proliferation index have been reported...

Full description

Bibliographic Details
Main Authors:	Feras Zaiem, Rada Jerbi, Omar Albanyan, Jordyn Puccio, Zyad Kafri, Jay Yang, Ali M Gabali
Format:	Article
Language:	English
Published:	Wolters Kluwer Medknow Publications 2020-10-01
Series:	Avicenna Journal of Medicine
Subjects:	activated b-cell (abc) bcl2 bcl6 b-lymphocytes cd10 cd23 cell-of-origin classification diffuse large b-cell lymphoma (dlbcl) germinal center b-cell (gcb) immunohistochemistry ki67 mum1 overall survival therapy response
Online Access:	http://www.thieme-connect.de/DOI/DOI?10.4103/ajm.ajm_81_20

Similar Items

Biweekly CHOP therapy improves therapeutic effect in the non-GCB subtype of diffuse large B-cell lymphoma
by: Zhang Qingyuan, et al.
Published: (2007-12-01)

Evaluation of BCL6 and MUM1 Expression in Patients with Diffuse Large B Cell Lymphoma (DLBCL) and Their Correlation with Staging and Prognosis of the Disease
by: Hossein Rahimi, et al.
Published: (2015-01-01)

Successful experience of treatment of a patient with generalized non-GCB- DLBCL using the R-mNHL-BFM-90 protocol with lenalidomide: case report and review of literature
by: N G GABEEVA, et al.
Published: (2018-07-01)

Poor outcome in patients with diffuse large B-cell lymphoma is associated with high percentage of bcl-2 and Ki 67-positive tumor cells
by: Peruničić-Jovanović Maja, et al.
Published: (2009-01-01)

Primary intraosseous lymphoma at right femur
by: P Upadhyaya, et al.
Published: (2015-09-01)

EphA2/CD10/Bcl-6/MUM1 contributes to subclassification of diffuse large B cell lymphoma
by: Xiaoyin Huang, et al.
Published: (2013-09-01)

Dysregulated TRAF3 and BCL2 Expression Promotes Multiple Classes of Mature Non-hodgkin B Cell Lymphoma in Mice
by: Gema Perez-Chacon, et al.
Published: (2019-01-01)

Oncogenic Mutations of MYD88 and CD79B in Diffuse Large B-Cell Lymphoma and Implications for Clinical Practice
by: Carlo Visco, et al.
Published: (2020-10-01)

A rare case of de novo CD5+ diffuse large B-cell lymphoma in leukemic phase and positive for CD13
by: Giovanni Carulli, et al.
Published: (2018-01-01)

Targeting the Bcl-2 Family in B Cell Lymphoma
by: Clare M. Adams, et al.
Published: (2019-01-01)

Overexpression of OCT-1 gene is a biomarker of adverse prognosis for diffuse large B-cell lymphoma (DLBCL): data from a retrospective cohort of 77 Brazilian patients
by: Gisele R. Gouveia, et al.
Published: (2020-10-01)

CD19-targeting CAR T Cells for Treatment of B Cell Malignancies : From Bench to Bedside
by: Karlsson, Hannah
Published: (2014)

CD14 as a potential prognostic factor and Bcl-2 as a therapeutic target in egyptian B-Cell chronic lymphocytic leukemia patients
by: Mohamed Mahmoud El-Khawanky, et al.
Published: (2019-01-01)

Evaluation of Bcl 2 and Ki 67 expression in Chronic Lymphocytic Leukemia .
by: Subh S. AL- Mudallal, et al.
Published: (2013-01-01)

When Imaging Predicts Aggressiveness of Large B Cell Lymphoma Biology
by: Minhas, Ahmed, et al.
Published: (2018)

BCL-2 Expression in Primary Cutaneous Follicle Center B-Cell Lymphoma and Its Prognostic Role
by: Alessandro Pileri, et al.
Published: (2020-04-01)

Partial Protection From Lupus-Like Disease by B-Cell Specific Type I Interferon Receptor Deficiency
by: Emma J. Keller, et al.
Published: (2021-01-01)

The Prognostic Significance of the KI-67 and CD-44 in Renal Cell Carcinomas
by: Şule Bakır, et al.
Published: (2005-01-01)

Induction of Th17 cell differentiation by B-1 cells
by: Yi eWang, et al.
Published: (2012-09-01)

A combination of the activation marker CD86 and the immune checkpoint marker B and T lymphocyte attenuator (BTLA) indicates a putative permissive activation state of B cell subtypes in healthy blood donors independent of age and sex
by: Susanne Axelsson, et al.
Published: (2020-03-01)

Prognostic impact of diffuse large B-cell lymphoma with extra copies of MYC, BCL2 and/or BCL6: comparison with double/triple hit lymphoma and double expressor lymphoma
by: Sixia Huang, et al.
Published: (2019-07-01)

Expressions of Bcl-2, Bax and Ki67 in the primary pterygium
by: Juan Li, et al.
Published: (2018-05-01)

A Case of a Rapidly Progressive Small Bowel Lymphoma with High Ki-67 Expression
by: Jiyeon Yoo, et al.
Published: (2017-03-01)

Evolution of Human Memory B Cells From Childhood to Old Age
by: Michela Ciocca, et al.
Published: (2021-07-01)

Análise imuno-histoquímica da Bcl-2, Bcl-6, c-Myc e ciclina D1 em linfomas de células B da região oral
by: Juvaní Lago Saturno
Published: (2014)

Análise imuno-histoquímica da Bcl-2, Bcl-6, c-Myc e ciclina D1 em linfomas de células B da região oral
by: Saturno, Juvaní Lago
Published: (2014)

Primary cutaneous peripheral T-cell lymphoma, not otherwise specified with mammalian target of rapamycin mutation: A novel finding for targeted treatment
by: Carlo De la Sancha, MD, et al.
Published: (2020-12-01)

Lower BCL11B expression is associated with adverse clinical outcome for patients with myelodysplastic syndrome
by: Xin Huang, et al.
Published: (2021-06-01)

B Cell and CD4 T Cell Interactions Promote Development of Atherosclerosis
by: Christopher Tay, et al.
Published: (2020-01-01)

Belimumab and Rituximab in Systemic Lupus Erythematosus: A Tale of Two B Cell-Targeting Agents
by: Leanna M. Wise, et al.
Published: (2020-06-01)

Molecular Insights into Lymphoid Malignancy : Role of Transcription Factor BCL11B in T-cell Leukemia Genesis and Biochemical Characterization of DNA Binding Domain of RAG1
by: Deepthi, R
Published: (2018)

Primary Diffuse Large B-Cell Lymphoma of the Sigmoid Colon
by: Minhas, Ahmed, et al.
Published: (2019)

BCL2-Family Dysregulation in B-Cell Malignancies: From Gene Expression Regulation to a Targeted Therapy Biomarker
by: Benoît Tessoulin, et al.
Published: (2019-01-01)

A Paradoxical Correlation of Cancer-Associated Fibroblasts With Survival Outcomes in B-Cell Lymphomas and Carcinomas
by: Marcela Haro, et al.
Published: (2018-08-01)

Rôle du CD40 dans la mort cellulaire
by: Jundi, Malek
Published: (2012)

Rôle du CD40 dans la mort cellulaire
by: Jundi, Malek
Published: (2012)

Clinical and Molecular Properties of Human Immunodeficiency Virus-Related Diffuse Large B-Cell Lymphoma
by: Pedro S. de Carvalho, et al.
Published: (2021-04-01)

Effect of Fluoride on Endocytosis and Surface Marker Expression Levels of Mouse B Cells In Vitro
by: Haili Ma, et al.
Published: (2016-07-01)

B cells negatively regulate the establishment of CD49b+T-bet+ resting memory T helper cells in the bone marrow
by: Shintaro eHojyo, et al.
Published: (2016-02-01)

CD9+ Regulatory B Cells Induce T Cell Apoptosis via IL-10 and Are Reduced in Severe Asthmatic Patients
by: Carole Brosseau, et al.
Published: (2018-12-01)